AMN Healthcare Posts Q4 Loss Despite $748M Revenue

Quarterly Revenue: The company generated <strong class="body_output text-content_primary font-semibold" node="[object Object]">$748 million in revenue for the fourth quarter of 2025.
GAAP Loss: AMN recorded a GAAP loss of <strong class="body_output text-content_primary font-semibold" node="[object Object]">($0.20) per share , a key metric indicating a net loss from operations.
Adjusted Earnings: On an adjusted basis, the company reported a positive <strong class="body_output text-content_primary font-semibold" node="[object Object]">earnings per share (EPS) of $0.22 .

AMN Healthcare announced its fourth-quarter and full-year 2025 financial results on February 19, 2026, revealing a complex picture for investors. The company reported quarterly revenue of $748 million. However, the top-line figure was contrasted by a GAAP (Generally Accepted Accounting Principles) loss of ($0.20) per share. This official loss figure suggests profitability challenges, even as the company presented a positive adjusted earnings per share (EPS) of $0.22 for the same period.

GAAP Loss Signals Potential Headwinds for Investors

The reported GAAP loss is a critical indicator for the market, often viewed as a more transparent measure of a company's financial health than adjusted figures, which can exclude certain expenses. This net loss is expected to trigger a negative reaction from investors and a re-evaluation by market analysts. The divergence between the GAAP loss and the positive adjusted EPS will likely become a focal point, raising questions about the company's long-term profitability and operational efficiency. The results could also influence broader sentiment within the healthcare staffing sector, as AMN serves as a key industry bellwether.

AMN Posts $748M Revenue But Reports $0.20 Per Share Loss

GAAP Loss Signals Potential Headwinds for Investors